Latest Vaccine Stories
Scientists have found a master regulator gene needed for the development of M cells, a mysterious type of intestinal cell involved in initiating immune responses. M cells act like "conveyor belts," ingesting bacteria and transporting substances from the gut into Peyer's patches, specialized tissues resembling lymph nodes in the intestines. Better knowledge of M cells' properties could aid research on oral vaccines and inflammatory bowel diseases. A team of researchers at Emory...
QUEBEC CITY, June 14, 2012 /PRNewswire/ - Medicago Inc. (TSX: MDG) (OTCQX: MDCGF), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that Mr. Pierre Labbé, Vice-President and Chief Financial Officer of Medicago, will be presenting at the Bloom Burton & Co. Healthcare Investment Conference. The conference is being held at the Toronto Board of...
FARMINGTON, Conn., June 13, 2012 /PRNewswire-iReach/ -- As the Chinese Livestock Markets suffer from frequent outbreaks of animal epidemics, both government and producers have demonstrated significant interest in veterinary health products. Having accurate demand forecasts and market analysis will be essential to companies seeking to compete in this fast-moving market. (Photo: http://photos.prnewswire.com/prnh/20120613/CG24191) Global Information is pleased to announce the...
SWIFTWATER, Pa. and WHITE PLAINS, N.Y., June 13, 2012 /PRNewswire/ -- As health departments across the country report record numbers of pertussis cases, the results of a new survey of American adults released today reveal that most parents aren't asking adults close to their infants and young children to get an adult pertussis booster vaccine, yet they do ask them to follow other basic precautions to safeguard their children's health. The survey was conducted online in May 2012 by...
An international team of scientists, funded in the UK by the Biotechnology and Biological Sciences Research Council (BBSRC), has uncovered the structure of the protective protein coat which surrounds many bacteria like a miniature suit of armor. Their research, which is published today (Sunday 10 June) in Nature, has far ranging consequences in helping us understand how some pathogenic bacteria infect humans and animals, and could help us develop new vaccines. Until now, scientists have...
Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in killing human papillomavirus-derived cancer, a virus linked to cervical cancers among others. The research was published in a recent issue of Cancer Immunology, Immunotherapy. "Vaccines for cancer can be good alternatives to conventional therapies that result in serious side-effects and are rarely effective against advanced disease," said Esteban Celis, M.D., Ph.D., senior...
GAITHERSBURG, Md., June 7, 2012 /PRNewswire/ -- GenVec, Inc. (NASDAQ: GNVC) today announced that the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) has issued a conditional license for GenVec's foot-and-mouth disease (FMD) vaccine for use in cattle. APHIS issued the conditional license to Antelope Valley Bios, Inc., who manufactured the vaccine under a contract from GenVec. The vaccine was developed and tested under a contract with the U.S....
No urgent need to get vaccinated to prevent a second shingles episode People who have had an episode of herpes zoster, also known as shingles, face a relatively low short-term risk of developing shingles, according to a Kaiser Permanente Southern California study published online in the Journal of Infectious Diseases. These findings suggest that among people with immune systems that have not been compromised, the risk of a second shingles episode is low. Researchers reviewed electronic...
VIENNA, June 5, 2012 /PRNewswire/ -- The worldwide first clinical trial for the development of a Parkinson's vaccine has now been started by AFFiRiS AG. The vaccine called PD01A is directed against alpha-Synuclein, a protein considered causing the onset and progression of the disease, and is currently being tested on Parkinson's patients in a Phase I trial. The vaccine holds out the prospect to deliver a causative treatment of Parkinson's for the first time. Its potential for...
UC health economics research has found that publication of perceived risk linking the MMR (measles, mumps, rubella) vaccine to autism in the late 1990s seemingly led to declines in the vaccination rate of children. This despite the fact that later studies refuted the existence of an MMR-autism link. New University of Cincinnati research has found that fewer parents in the United States vaccinated their children in the wake of concerns about a purported link (now widely discredited) between...
Latest Vaccine Reference Libraries
Yellow fever is an acute viral hemorrhagic disease with a 40 to 50 nm enveloped RNA virus with positive sense of the Flaviviridae family. It is transmitted by the bite of female mosquitoes and is found in tropical and subtropical areas in South America and Africa, but not in Asia. Primates and a few kinds of mosquitoes are the only known hosts. The origin of the disease is most likely Africa. From there it was introduced to South America through the slave trade in the 16th century. There...
A virus is a small infectious agent that replicates inside the living cells of organisms. It is a small infectious agent that can replicate only inside the living cells of organisms. Most are too small to be seen by anything but a microscope and they infect all organisms from animals to plants to bacteria. The first one discovered was the tobacco virus in 1898. Since then around 5,000 viruses have been described in detail although there are millions of different types. They are found in...
Foot-and-mouth disease, FMD, is sometimes fatal and is highly contagious for cloven-hoofed animals. Along with hooved animals hedgehogs and elephants are susceptible to the disease as well. Llama and alpaca can develop mild symptoms but are resistant to the disease and don't pass it to other species. Mice, rats, and chickens have been infected artificially in a lab but it is not believed they can contract the disease under natural conditions. Humans can spread the disease by carrying the...
